Analysis of total and transferrin-bound iron in human serum for pharmacokinetic studies of iron-sucrose formulations.

Background: Patients with iron-deficiency anemia benefit from intravenous iron therapies. Development of these pharmaceutical agents requires pharmacokinetic studies monitoring levels of both the administered agent and transferrin-bound iron (TBI). Successful pharmacokinetic methods must discriminate iron species.